Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity

Simon Andreasen, Justin A. Bishop, Henrik Hellquist, Jennifer Hunt, Katalin Kiss, Alessandra Rinaldo, Alena Skálová, Stefan M. Willems, Michelle Williams, Alfio Ferlito

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Biphenotypic sinonasal sarcoma (BSNS) is a recently recognized type of sarcoma arising exclusively in the sinonasal tract displaying unique clinical course, histopathology, and genetics. Due to its rarity, only case series and case reports are available. In order to provide an overview of the current understanding of this disease, we present a comprehensive review of the literature and present three previously unreported cases of BSNS. A total of 55 genetically characterized and 41 cases without molecular data were identified in the literature. Two-thirds of patients were female and the peak incidence was in the fifth decade. Fatal outcome was rare (two cases with intracranial extension) and local recurrence occurred in 31.6%, all occurring within 5 years after initial treatment. Histologically, BSNS is highly cellular in the majority of cases and composed of fascicles of spindle cells, with entrapped hyperplastic surface epithelium being a frequent finding. The immunohistochemical profile is characteristic due to the biphasic nature of this lesion, with shared features of both myogenic and neural origin. Rhabdomyoblastic differentiation is apparent in a subset of cases. The most common genetic event is the PAX3-MAML3 fusion (58.6%) but isolated PAX3 rearrangement (19.2%), absence of rearrangements (9.1%), PAX3-FOXO1 (8.1%), PAX3-NCOA1 (4%), and isolated MAML3 rearrangement (2%) have also been reported. In conclusion, the recognition of BSNS is crucial due to its relatively indolent clinical course. A selected immunohistochemical panel and/or molecular confirmation can be used to aid in appropriate diagnosis and consequently in prognostication and to avoid overtreatment with chemotherapy regimens used in its mimics.

Original languageEnglish (US)
JournalVirchows Archiv
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Sarcoma
Demography
Fatal Outcome
Epithelium
Recurrence
Drug Therapy
Incidence
Therapeutics

Keywords

  • Biphenotypic sinonasal sarcoma
  • PAX3-MAML3
  • PAX3-NCOA1
  • Prognosis
  • Recurrence
  • Sinonasal sarcoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Biphenotypic sinonasal sarcoma : demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity. / Andreasen, Simon; Bishop, Justin A.; Hellquist, Henrik; Hunt, Jennifer; Kiss, Katalin; Rinaldo, Alessandra; Skálová, Alena; Willems, Stefan M.; Williams, Michelle; Ferlito, Alfio.

In: Virchows Archiv, 01.01.2018.

Research output: Contribution to journalArticle

Andreasen, Simon ; Bishop, Justin A. ; Hellquist, Henrik ; Hunt, Jennifer ; Kiss, Katalin ; Rinaldo, Alessandra ; Skálová, Alena ; Willems, Stefan M. ; Williams, Michelle ; Ferlito, Alfio. / Biphenotypic sinonasal sarcoma : demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity. In: Virchows Archiv. 2018.
@article{a7a666758e6c450d9755e24f93f737cd,
title = "Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity",
abstract = "Biphenotypic sinonasal sarcoma (BSNS) is a recently recognized type of sarcoma arising exclusively in the sinonasal tract displaying unique clinical course, histopathology, and genetics. Due to its rarity, only case series and case reports are available. In order to provide an overview of the current understanding of this disease, we present a comprehensive review of the literature and present three previously unreported cases of BSNS. A total of 55 genetically characterized and 41 cases without molecular data were identified in the literature. Two-thirds of patients were female and the peak incidence was in the fifth decade. Fatal outcome was rare (two cases with intracranial extension) and local recurrence occurred in 31.6{\%}, all occurring within 5 years after initial treatment. Histologically, BSNS is highly cellular in the majority of cases and composed of fascicles of spindle cells, with entrapped hyperplastic surface epithelium being a frequent finding. The immunohistochemical profile is characteristic due to the biphasic nature of this lesion, with shared features of both myogenic and neural origin. Rhabdomyoblastic differentiation is apparent in a subset of cases. The most common genetic event is the PAX3-MAML3 fusion (58.6{\%}) but isolated PAX3 rearrangement (19.2{\%}), absence of rearrangements (9.1{\%}), PAX3-FOXO1 (8.1{\%}), PAX3-NCOA1 (4{\%}), and isolated MAML3 rearrangement (2{\%}) have also been reported. In conclusion, the recognition of BSNS is crucial due to its relatively indolent clinical course. A selected immunohistochemical panel and/or molecular confirmation can be used to aid in appropriate diagnosis and consequently in prognostication and to avoid overtreatment with chemotherapy regimens used in its mimics.",
keywords = "Biphenotypic sinonasal sarcoma, PAX3-MAML3, PAX3-NCOA1, Prognosis, Recurrence, Sinonasal sarcoma",
author = "Simon Andreasen and Bishop, {Justin A.} and Henrik Hellquist and Jennifer Hunt and Katalin Kiss and Alessandra Rinaldo and Alena Sk{\'a}lov{\'a} and Willems, {Stefan M.} and Michelle Williams and Alfio Ferlito",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s00428-018-2426-x",
language = "English (US)",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Biphenotypic sinonasal sarcoma

T2 - demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity

AU - Andreasen, Simon

AU - Bishop, Justin A.

AU - Hellquist, Henrik

AU - Hunt, Jennifer

AU - Kiss, Katalin

AU - Rinaldo, Alessandra

AU - Skálová, Alena

AU - Willems, Stefan M.

AU - Williams, Michelle

AU - Ferlito, Alfio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Biphenotypic sinonasal sarcoma (BSNS) is a recently recognized type of sarcoma arising exclusively in the sinonasal tract displaying unique clinical course, histopathology, and genetics. Due to its rarity, only case series and case reports are available. In order to provide an overview of the current understanding of this disease, we present a comprehensive review of the literature and present three previously unreported cases of BSNS. A total of 55 genetically characterized and 41 cases without molecular data were identified in the literature. Two-thirds of patients were female and the peak incidence was in the fifth decade. Fatal outcome was rare (two cases with intracranial extension) and local recurrence occurred in 31.6%, all occurring within 5 years after initial treatment. Histologically, BSNS is highly cellular in the majority of cases and composed of fascicles of spindle cells, with entrapped hyperplastic surface epithelium being a frequent finding. The immunohistochemical profile is characteristic due to the biphasic nature of this lesion, with shared features of both myogenic and neural origin. Rhabdomyoblastic differentiation is apparent in a subset of cases. The most common genetic event is the PAX3-MAML3 fusion (58.6%) but isolated PAX3 rearrangement (19.2%), absence of rearrangements (9.1%), PAX3-FOXO1 (8.1%), PAX3-NCOA1 (4%), and isolated MAML3 rearrangement (2%) have also been reported. In conclusion, the recognition of BSNS is crucial due to its relatively indolent clinical course. A selected immunohistochemical panel and/or molecular confirmation can be used to aid in appropriate diagnosis and consequently in prognostication and to avoid overtreatment with chemotherapy regimens used in its mimics.

AB - Biphenotypic sinonasal sarcoma (BSNS) is a recently recognized type of sarcoma arising exclusively in the sinonasal tract displaying unique clinical course, histopathology, and genetics. Due to its rarity, only case series and case reports are available. In order to provide an overview of the current understanding of this disease, we present a comprehensive review of the literature and present three previously unreported cases of BSNS. A total of 55 genetically characterized and 41 cases without molecular data were identified in the literature. Two-thirds of patients were female and the peak incidence was in the fifth decade. Fatal outcome was rare (two cases with intracranial extension) and local recurrence occurred in 31.6%, all occurring within 5 years after initial treatment. Histologically, BSNS is highly cellular in the majority of cases and composed of fascicles of spindle cells, with entrapped hyperplastic surface epithelium being a frequent finding. The immunohistochemical profile is characteristic due to the biphasic nature of this lesion, with shared features of both myogenic and neural origin. Rhabdomyoblastic differentiation is apparent in a subset of cases. The most common genetic event is the PAX3-MAML3 fusion (58.6%) but isolated PAX3 rearrangement (19.2%), absence of rearrangements (9.1%), PAX3-FOXO1 (8.1%), PAX3-NCOA1 (4%), and isolated MAML3 rearrangement (2%) have also been reported. In conclusion, the recognition of BSNS is crucial due to its relatively indolent clinical course. A selected immunohistochemical panel and/or molecular confirmation can be used to aid in appropriate diagnosis and consequently in prognostication and to avoid overtreatment with chemotherapy regimens used in its mimics.

KW - Biphenotypic sinonasal sarcoma

KW - PAX3-MAML3

KW - PAX3-NCOA1

KW - Prognosis

KW - Recurrence

KW - Sinonasal sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85051708608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051708608&partnerID=8YFLogxK

U2 - 10.1007/s00428-018-2426-x

DO - 10.1007/s00428-018-2426-x

M3 - Article

C2 - 30109475

AN - SCOPUS:85051708608

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

ER -